Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Rossignol

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
American Journal of Hematology|September 17, 2024
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurinMaël Heiblig, Clément Gourguechon, Philippe Guilpain, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control studyAnne Laure Roupie, Alexis Guedon, Benjamin Terrier, et al.
Cancer Research|April 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell LymphomaYuta Ito, Amira Marouf, Yasunori Kogure, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
American Journal of Hematology|September 17, 2024
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurinMaël Heiblig, Clément Gourguechon, Philippe Guilpain, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control studyAnne Laure Roupie, Alexis Guedon, Benjamin Terrier, et al.
Cancer Research|April 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell LymphomaYuta Ito, Amira Marouf, Yasunori Kogure, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 14